ARCHIVES

Three Nominated To ET2; NCI Seeks Clinical Applications

This article is from The Cancer Letter archive.

Vol. 17 No. 21 | May 24, 1991

Download PDF Visit The Full Archive

Related Articles

John Ultmann, Chicago’s Outspoken Director, Heads In Retirement

August 30, 1991

Clinical Trials: ECOG Says Results In Metastatic disease equivalent, Unlikely To change Over Time

April 16, 1999

In Brief: Ahoy! It’s “Admiral Rick”

April 2, 1999

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

November 8, 2013

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

February 22, 2013

Coffey Presses NCI BSA chairman David Linvingston On support For Increase In NCI Budget

April 25, 1997